 |
Articles: Clinical Pharmacology |
Comparison between lidocaine-prilocaine cream (EMLA) and mepivacaine infiltration for pain relief during perineal repair after childbirth: a randomized trial
American Journal of Obstetrics and Gynecology, 07/02/09
Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
Therapeutics and Clinical Risk Management, 07/02/09
Free full text
Prior Articles
Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel
Cancer, 07/01/09 Is the current concept of recurrent ovarian carcinoma as a chronic disease also applicable in platinum resistant patients
Archives of Gynecology and Obstetrics, 07/01/09 Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer
Gynecologic Oncology, 07/01/09 Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission
Acta Obstetricia et Gynecologica Scandinavica, 07/01/09 Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma
Gynecologic Oncology, 06/30/09 Patient Satisfaction in Postmenopausal Women Treated with a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate
Journal of Women's Health, 06/30/09 Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest
The European Journal of Contraception & Reproductive Health Care, 06/30/09 Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial
Gynecologic Oncology, 06/30/09 Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: Results of a single-institutional phase II study
Gynecologic Oncology, 06/30/09 Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group
Gynecologic Oncology, 06/30/09 Southwest Oncology Group Trial S9912: Intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer
Gynecologic Oncology, 06/30/09 Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena) and depot-medroxyprogesterone acetate (Depo-Provera) on subendometrial microvascularisation and uterine artery blood flow
The European Journal of Contraception & Reproductive Health Care, 06/30/09 Increasing womens choices in medical abortion: A study of misoprostol 400 ug swallowed immediately or held sublingually following 200 mg mifepristone
The European Journal of Contraception & Reproductive Health Care, 06/30/09 Dienogest and the breast
Gynecological Endocrinology, 06/29/09 Interval of Injections of Intramuscular Depot Medroxyprogesterone Acetate in the Long-Term Treatment of Endometriosis-Associated Pain: A Randomized Comparative Trial
Gynecologic and Obstetric Investigation, 06/29/09 Once-yearly Aclasta approved in EU to treat osteoporosis caused by steroid treatment in men and postmenopausal women
Novartis, 06/29/09
Free full text
Hepatotoxicity during low-dose flutamide treatment for hirsutism
Gynecological Endocrinology, 06/29/09 Metformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome
Gynecological Endocrinology, 06/29/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Obstetrics and Gynecology, American Journal of Obstetrics and Gynecology
more...
|
250 Available Pages
|
|
